Literature DB >> 18177931

Hemodynamic alterations in liver cirrhosis.

Giorgio La Villa1, Paolo Gentilini.   

Abstract

In cirrhotic patients, portal hypertension is often associated with a hyperdynamic circulatory syndrome, with high cardiac output and reduced systemic vascular resistance and arterial pressure. The hyperdynamic circulatory syndrome is due to arterial vasodilation that mainly occurs in the splanchnic circulation, while vascular resistance in the other circulatory districts is normal or increased, accordingly with the degree of portal hypertension, liver impairment and activation of the renin-aldosterone and sympathetic nervous system. The mechanism(s) leading to splanchnic vasodilation is unclear. A favored hypothesis translocation of intestinal bacteria and/or some their products, such as endotoxin, into the interstitial space in the splanchnic organs results in the local release of vasodilating factors such as nitric oxide, carbon monoxide and others.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177931     DOI: 10.1016/j.mam.2007.09.010

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  12 in total

1.  Vascular Doppler ultrasonographic indices in cirrhosis: a case-control study with emphasis on the common carotid arteries.

Authors:  Abolhassan Shakeri; Mojtaba Varshochi; Naser Atapour; Masoud Nemati; Manoochehr Khoshbaten; Daniel Fadaei Fouladi
Journal:  Radiol Med       Date:  2015-03-01       Impact factor: 3.469

2.  Evaluation of the renal resistive index and pulsatility index in patients with pleural effusion by duplex Doppler ultrasonography.

Authors:  Nevbahar Akcar Değirmenci; Muzaffer Metintaş; Sahinde Atlanoglu; Huseyin Yıldırım
Journal:  Jpn J Radiol       Date:  2012-10-10       Impact factor: 2.374

3.  Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy.

Authors:  Camila Marques; Francielli Licks; Ingrid Zattoni; Beatriz Borges; Luiz Eduardo Rizzo de Souza; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

4.  Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis.

Authors:  Yavuz Beyazit; Mehmet Ibis; Tugrul Purnak; Turan Turhan; Murat Kekilli; Mevlut Kurt; Abdurrahim Sayilir; Ibrahim Koral Onal; Nesrin Turhan; Adnan Tas; Seyfettin Köklü; Ibrahim C Haznedaroglu
Journal:  Dig Dis Sci       Date:  2011-02-03       Impact factor: 3.199

5.  Abnormal splenic artery diameter/hepatic artery diameter ratio in cirrhosis-induced portal hypertension.

Authors:  Dao-Bing Zeng; Chuan-Zhou Dai; Shi-Chun Lu; Ning He; Wei Wang; Hong-Jun Li
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

6.  Clinically severe portal hypertension: role of multi-detector row CT features in diagnosis.

Authors:  Ji Young Lee; Tae Yeob Kim; Woo Kyoung Jeong; Yongsoo Kim; Jinoo Kim; Kyoung Won Kim; Young Hwan Kim; Joo Hyun Sohn
Journal:  Dig Dis Sci       Date:  2014-04-11       Impact factor: 3.199

7.  Quantitative modeling of the physiology of ascites in portal hypertension.

Authors:  David G Levitt; Michael D Levitt
Journal:  BMC Gastroenterol       Date:  2012-03-27       Impact factor: 3.067

8.  The content of hydrogen sulfide in plasma of cirrhosis rats combined with portal hypertension and the correlation with indexes of liver function and liver fibrosis.

Authors:  Weiwei Wei; Chao Wang; Dongjian Li
Journal:  Exp Ther Med       Date:  2017-09-19       Impact factor: 2.447

Review 9.  High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice.

Authors:  Diane Xavier de Ávila; Humberto Villacorta; Wolney de Andrade Martins; Evandro Tinoco Mesquita
Journal:  Curr Cardiol Rev       Date:  2022

10.  Association Between Changes in Splanchnic Hemodynamics and Risk Factors of Portal Venous System Thrombosis After Splenectomy with Periesophagogastric Devascularization.

Authors:  Long Huang; Qingsheng Yu; Jiajia Wang
Journal:  Med Sci Monit       Date:  2018-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.